Details of the Drug Reposition

General Information of This Drug (ID: DMLPAFG)

Drug Name	CD19-targeted CAR-T cells DMLPAFG
Drug Type	CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Clinical trial Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
leukaemia	DISS7D1V	2A60-2B33	Clinical trial	[1]
Lymphoma	DISN6V4S	2A80-2A86	Clinical trial	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02735291) Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia
2	ClinicalTrials.gov (NCT02728882) Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma